Q: Hello, SIS announced a couple of days ago it is increasing the dividend by 17% and provided its update on 2018 and 2019 guidance. The market welcomed the announcement with an upswing of 5%. But today again, it is down by 3%. The volatility is not matching with the market movement. Yes , the shares are up compared to a year ago. But still the movement of the stock is becoming un predictable to large extent. Is there any other news that I have missed on this counter. Thanks for your advice always.
Q: My feeling about the cannabis stocks is that they are over-valued. I feel that the bikers/current suppliers are not just going to disappear after Oct.18th. Can you suggest a good way to short the sector?
Q: Can you provide an update on this company.It is performing very well technically.Can you comment on fundamentals including valuation and growth going forward.What is driving the stock price?
Would you recommend an initial position?
Thanks
Q: Medical technology was mentioned as high growth in a recent article, do you have any comments on companies this area and specifically Teladoc..
Love your service
Q: Could you please give me your analysis/view on BlackRock Health Sciences CEF (BME). It appears to have a very good income and performance track record.
Q: Abbvie has not done well since my relatively recent purchase. Down approcimately 7%. Would you suggest selling and making another purchase in the same sector?
With appeciation.
Ed
Q: hi Peter if the 100 million contact with the Saudi's is lost say TODAY what is the material affect to COV.? ie. 1. what would be the new revised P/E ratio? and. 2. what is your best guess as to the new lower trading price per share ? 3. does your forecast of 35 cents to 40cents per share for 2019 assume a favourable resolution of this issue? 4. what percent of equity is currently owned by executives and insiders? thanks Richard
Q: I have set 8% sector target and have invested 50% - GUD 15% of total target, TD Health Sciences 11%, and 9% each to ISRG, ILMN, and COV.
If I drop TD Fund, then 60% available to reinvest - what names and allocations do you advise?
Thx for your excellent advice,
Sam
Q: You have mentioned that you dislike companies that tend to put out too many press releases. I own Reliq Health Technologies and am often surprised at what they consider worth communicating. The other day the press release headline was "Reliq Health Technologies receives second hardware shipment". Today they put out " Reliq Health Technologies Kick Off Patient Onboarding at Rio Grande Valley Health Alliance in Texas". I'm not sure that these qualify as huge milestones that the public and shareholders really need to know and they seem to be self-promotional. Would you consider RHT as a company that does too much self-promoting and does it cause you any concern?